Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

NCT: NCT02290834 · RECRUITING

NCT IDNCT02290834
StatusRECRUITING
Start Date2015-03
Completion2028-01
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

This research study evaluates the effect of chemotherapy on cognition (thinking) and the brain in people with breast cancer.

Frequently Asked Questions

What is Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer?

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer is a clinical trial registered under NCT02290834. Current status: RECRUITING.

What is the status of NCT02290834?

The current status of NCT02290834 (Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer) is: RECRUITING.

When did Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer start?

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer started on 2015-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑